News for Viking Therapeutics, Inc. (0VQA.L)

B. Riley has adjusted its price target for Viking Therapeutics (VKTX), lowering it from $96 to $85. Despite this adjustment, the firm maintains a Buy rating on

Research and Development Expenses: $41.4 million for Q1 2025, up from $24.1 million in Q1 2024.General and Administrative Expenses: $14.1 million for Q1 2025,

Highlights: Viking Therapeutics Inc. (VKTX) is gaining attention due to potential acquisition interest and promising drug developments. Analysts project

Viking Therapeutics is making significant strides in obesity treatment with its drug VK2735. Analysts suggest a substantial potential upside for VKTX st

We recently published a list of 20 Takeover Rumors Hedge Funds Are Buying. In this article, we are going to take a look at where Viking Therapeutics, Inc.

Key Takeaways: Viking Therapeutics faces increased net losses due to significant research and development expenses. The company's stock holds substantial

Summary Viking Therapeutics Inc (VKTX), a clinical-stage biopharmaceutical company specializing in metabolic and endocrine disorder therapies, released its fina

PR NewswireSAN DIEGO, April 23, 2025 Conference call scheduled for 4:30 p.m. ET todayPhase 3 Trials for Subcutaneous VK2735 Expected to Begin 2Q25Phase 2 V

U.S. stock futures were higher this morning, with the Dow futures gaining around 400 points on Friday. Shares of Apple Inc. AAPL fell sharply in today's pre-ma...

In the latest trading session, Viking Therapeutics, Inc. (VKTX) closed at $23.91, marking a -0.99% move from the previous day.

Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics VKTX. And retail traders should know. We noticed this today when the...

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.28, indicating a +1.14% shift from the previous trading day.

Investors with a lot of money to spend have taken a bearish stance on Viking Therapeutics VKTX. And retail traders should know. We noticed this today when the...

In the closing of the recent trading day, Viking Therapeutics, Inc. (VKTX) stood at $29.73, denoting a +0.61% change from the preceding trading day.

We recently published a list of 10 Stocks Skyrocketing Today. In this article, we are going to take a look at where Viking Therapeutics Inc.

High-rolling investors have positioned themselves bullish on Viking Therapeutics VKTX, and it's important for retail traders to take note. \This activity came t...

PR NewswireSAN DIEGO, March 11, 2025 Long-Term Agreement Secures Dedicated Capacity for Multi-Ton Annual Supply of VK2735 Active Pharmaceutical Ingredient

In the most recent trading session, Viking Therapeutics, Inc. (VKTX) closed at $29.10, indicating a +1.46% shift from the previous trading day.

U.S. stocks were lower, with the Dow Jones falling over 500 points on Thursday. Shares of BJ’s Wholesale Club Holdings, Inc. BJ rose sharply during Thursday'...